Trial Profile
BNP [nesiritide] as adjuvant therapy to preserve renal function and facilitate diuresis in hospitalized patients with heart failure
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Nesiritide (Primary)
- Indications Decompensated heart failure; Heart failure
- Focus Pharmacodynamics
- 17 Nov 2009 Additional lead trial investigator (Redfield MM) identified as reported by ClinicalTrials.gov.
- 17 Nov 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 19 Nov 2005 New trial record.